Across 37 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by 류 기 성, Executive. Insider active across 2 companies, notably 경동제약. Cumulatively, 60 filings have been logged. History available since 26 February 2026. The latest transaction was disclosed on 26 February 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Ryu Gi-seong is an executive at Kyungdong Pharmaceutical, a company active in the pharmaceutical sector. His role focuses on managing operations and the strategic development of the company.